The migration markers were extended beyond CD44 and IL-6 to include the second hyaluronic acid receptor HMMR,27 CD276,28 which is involved in the epithelial-mesenchymal transition, as well as the two cytokines IL-829 and TNF,30 both of which play important roles in GBM. The gene discussed is LYVE1; the disease is glioblastoma.